Amplia Therapeutics Ltd. (AU:ATX) has released an update.
Amplia Therapeutics Ltd. has announced the proposed issuance of new securities, including options priced at $0.1725 set to expire on October 31, 2027, and over 2.8 million ordinary shares. This move, scheduled for December 10, 2024, highlights Amplia’s strategic financial maneuvering to potentially bolster its market presence.
For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.
